Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.
- Conditions
- Corneal Epithelium
- Interventions
- Procedure: Epi-LASK
- Registration Number
- NCT00599690
- Lead Sponsor
- Asociación para Evitar la Ceguera en México
- Brief Summary
To evaluate the confocal microscopy findings at the corneal epithelium and anterior stroma after epi-LASIK Surgery.
- Detailed Description
10 eyes of 10 patients underwent epi-LASK, epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes. A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) before and at 2 weeks and 1 month after surgery. Corneal epithelial thickness and the Anterior stroma morphology were analyzed by using the NAVIS software V. 3.5.0 (NIDEK, Multi-Instrument Diagnostic System, Japan).
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
- Patients asking for epi-LASIK surgery
- Patients with stable refraction in the last year
- Patients without systemic and ocular disease
- Patients with 500 microns in pachymetry
- Normal topography
- Patients cannot attend their appointments
- Residual, recurrent or active ocular disease
- Previous ocular surgery except LASIK
- Autoimmune or connective tissue disease
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A Epi-LASK Epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes
- Primary Outcome Measures
Name Time Method A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) Before and at 2 weeks and 1 month after surgery
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures specified for this study There are no secondary outcome measures specified for this study
Trial Locations
- Locations (1)
Asociación Para Evitar la Ceguera en Mëxico, Hospital "Luis Sánchez Bulnes".
🇲🇽Mexico city, Distrito Federal, Mexico